Tissue sampling, processing and staining

Welcome to the home of 'Tissue sampling'

These pages include chapters on sampling, fixation and processing of tissue through to staining, microscopy and whole slide imaging. At the end of this section, you can also find comprehensive chapter on whole mount, large format histology. Atlases of normal tissues and special stains can be found at the end of the chapter on 'Staining'. The books 'Tissue processing: From patient to pathologist' and 'Pathological bodies' are both available on Amazon.

In addition to 'Pathological bodies', you can click on the 'PathoFocus' tab above to access my other website on the pathology of disease processes. The 'Publications' tab will take you to my books, journal and web-based publications and blogs and international presentations. I do hope you enjoy your visit and please feel free to post a comment.Following your visit, why not pop across to the 'Atlas of medical foreign bodies'. Compiled by Dr Yale Rosen, a New York pathologist, you can access it at https://t.co/tJ8RajYSlL

Sampling of tissue outside the laboratory

Biopsies are invasive procedures and should be performed as a result of clinical indications and with a genuine possibility of therapeutic benefit. For the patient, tissue sampling is not without risk and the most important of them are described at the end of this chapter. Imaging methods are routinely used for obtaining certain tissue samples although most radiographic evaluations are confined to breast disease. Microcalcification can sometime mark the site of a neoplastic lesion in the breast where radiology can be used to locate tiny lesions that may not be obvious on palpation or laboratory examination. Routine breast radiography should certainly be done when initial sampling fails to reveal a lesion that has been picked up on mammography. There are several imaging methods that can be employed in the sampling of breast and other tissues and these are included in the alphabetic list of sampling methods below.

Advanced Breast Biopsy Instrumentation (ABBI)

Using the X-ray / coordinate combination, the ABBI system uses an imaging table which displays pictures of the patient’s breast in snapshot form. A needle is then inserted into the selected area and a tissue core from 5 mm to 20 mm in diameter is removed. ABBI has been available since 1996, and marked a significant advance over the previous biopsy technique of wire localization

Advanced Breast Biopsy Instrumentation

Brush biopsy

Brush biopsy

This technique is used for sampling the ureter as well as for detecting cancers in the mouth, bronchus, biliary tract and oesophagus. For tissue samples of the ureter for example, the method of retrograde brush biopsy cytology is used. In this method, a cystoscope enters through the urethra and the bladder in order for a guidewire to gain access to the ureter. A catheter is then passed over the guide wire and a contrast dye is instilled through it which enables positioning next to the lesion using fluoroscopy. After irrigation with saline solution, a nylon or steel brush is placed through the catheter and the lesion is rubbed with the brush. This is repeated several times using a new brush each time. When the brush is removed, the tip of the brush is saved and tissue from the lesion is removed from the brush tip. After the last brushing, the area is irrigated with saline and this is also sent for examination

Computed tomography (CT)

This is a diagnostic technique in which the combined use of a computer and X rays passed through the body at different angles produces clear cross-sectional images of the tissue under examination. CT scanning, also known as computed axial tomography (CAT scanning) is particularly useful for locating and imaging tumours and for facilitating needle biopsies

Computed tomography

Cone biopsy

Cone biopsy

In this specialized technique, a small cone-shaped sample of tissue is removed from the inner surface of the cervix. Cone biopsies are used to diagnose cervical cancer in patients with either an abnormal cervical smear or punch biopsy

Core biopsy

These are performed in much the same way as a fine needle aspiration but with a larger bore needle. After a local anaesthetic, a small nick is made in the skin with a scalpel and the biopsy needle is injected through the nick and into the lump, removing a core of tissue. Core biopsies of kidney and palpable breast abnormalities may be performed with or without image guidance and usually provides a reliable histological diagnosis

Core biopsy

Crosby-Kugler capsule

Crosby-Kugler capsule

Capsule biopsies of jejunal mucosa for the investigation of malabsorption states can be assessed by stereomicroscopy where the architecture of the villous surface is clearly seen. Correct orientation of the mucosa will make interpretation easier

Curettings

Curetted specimens are awkward to orientate, but this is often only of importance with skin lesions. While there is little problem in identifying simple warts in these samples, differentiating between squamous cell carcinomas and other lesions may prove difficult. On the other hand, uterine curettings are usually obtained in sufficient quantity for adequate diagnosis

Currettings (uterine)

Ductal lavage

Ductal lavage

This test is carried out by inserting a tiny catheter into the nipple where a small amount of fluid is removed from the ductal cells after a saline flush

Endoscopic biopsy

This is a general term that refers to biopsy samples obtained by using endoscopes, special fibre optic instruments with miniature forceps at the end that can be passed into certain parts of the body. They are commonly used to take biopsy samples from areas such as the stomach (gastroscopy), the colon (colonoscopy or sigmoidoscopy), the bladder (cystoscopy), the lungs (bronchoscopy), the joints (arthroscopy) and the cervix (colposcopy). Laparoscopes are endoscopes for the examination of the abdominal cavity and are used in laparoscopic (keyhole) surgery for the removal of tissues such as the gall bladder

Endoscopic biopsy

ERCP

Endoscopic retrograde cholangiopancreatography (ERCP)

This is a technique that combines the use of endoscopy and fluoroscopy to diagnose and treat certain problems of the biliary or pancreatic ductal systems. Through the endoscope, the physician can see the inside of the stomach and duodenum, and inject radiographic contrast into the ducts in the biliary tree and pancreas so they can be seen on X-rays. ERCP is used primarily to diagnose and treat conditions of the bile ducts and main pancreatic duct, including gallstones, inflammatory strictures (scars), leaks (from trauma and surgery), and cancer. ERCP can be performed for diagnostic and therapeutic reasons, although the development of safer and relatively non-invasive investigations such as magnetic resonance cholangiopancreatography (MRCP) and endoscopic ultrasound has meant that ERCP is now rarely performed without therapeutic intent

Evacuation

Surgical evacuation of the uterus for management of incomplete abortion, usually involves vacuum aspiration using a cannula

Evacuation using cannula

Excision biopsy

Excision biopsy

This is a surgical procedure performed on a lump that is small enough to be removed easily. Sometimes an entire tumour with a small rim (or margin) of normal tissue around it is removed. This technique is commonly used to remove relatively small and easily accessible masses. Surgeons should always mark the excisional biopsy margins with sutures or metal clips so that if removal is incomplete and further excision is needed the margin of previous excision can be properly located (compare with incisional biopsy)

Fine needle aspiration (FNA)

This is the process of extracting cells from a lump such as that found in the breast by using a very thin, fine, hollow needle and syringe. This technique is used alone when the mass can be clearly palpated through the skin. For subtle or deep lesions the procedure is used along with X-ray or ultrasound guidance

Fine needle aspiration

Fluoroscopy

Fluoroscopy

This is a method for obtaining X-ray images and is used during many diagnostic and therapeutic procedures. Fluoroscopy is also used to observe the action of instruments during biopsy techniques. During this procedure, a transmitted X-ray beam strikes a fluorescent plate which is coupled to an image intensifier and monitor. Fluoroscopy is often used to observe the digestive tract after a barium enema

Frozen section

This is a rapid process that allows the pathologist to give the surgeon an immediate diagnosis while the patient is still in the operating room. In this procedure, a fresh tissue sample is removed and sent to the laboratory where it is frozen and cut in a cryostat. Microscopic slides are then prepared and examined by a pathologist who can determine whether the tissue is benign or malignant

Frozen section

Imprint smear

Imprint smear

This is a method whereby a smear is prepared by pressing the cut surface of a freshly dissected sample (such as lymph node) onto the surface of a microscope slide. This results in a thin layer of cells which can be stained and examined microscopically

Incision biopsy

This refers to a surgical technique used to sample a large, sometimes inaccessible mass which cannot be easily removed. The surgeon cuts into the mass and removes a sample which is then used to establish a definitive diagnosis of cancer before performing major surgery. Orientation of biopsy incisions is extremely important since ill-conceived incisions can unnecessarily open up additional tissue planes, necessitating more extensive ultimate surgical resections (compare with excisional biopsy)

Incision biopsy

Liquid based cytology

Liquid based cytology (LBC)

This is an automated alternative to the conventional cervical (Pap) smear. In the LBC (Thinprep) system, a sample from the cervix is collected using a brush type plastic device which is then detached into a vial of transport medium. In the laboratory, the tubes are vortex mixed and the suspension passed through a density gradient centrifugation process to remove mucus and blood cells. The cell pellet is then resuspended and a thin layer sample transferred to a microscope slide which can then be stained and examined microscopically

Loop electrosurgical excision procedure (LEEP)

This is one of the most commonly used approaches to treat high grade cervical dysplasia discovered on colposcopic examination. In the UK it is known as large loop excision of the transformation zone (LLETZ).The procedure has many advantages including low cost, high success rate, and ease of use. The procedure can be done in an office setting and usually only requires a local anaesthetic

Loop electrosurgical excision procedure

Magnetic resonance imaging

Magnetic resonance imaging (MRI)

This is a non-invasive imaging technique which uses a strong magnet and radiofrequency waves to produce images of internal organs. The clinical role of MRI in cancer imaging includes determining the true edges of tumours prior to surgery, differentiating palpable masses from scar or dense tissue and detecting occult breast cancers mammographically and sonographically in patients with axillary nodal metastases. Though MRI has potential applications, it is not routinely used in breast cancer

Mammography

The mammogram is an X-ray of the breast which is able to detect cancer at an early and curable stage. Mammography can identify breast cancers that are too small to be palpated by physical examination and can also detect the presence of localised lumps. Digital mammography is an emerging technique which uses computers and specially designed detectors to produce a digital image of the breast that can be displayed on high-resolution monitors. However, these tests cannot say whether the cancer is benign or malignant so a biopsy is needed to confirm the diagnosis. Vacuum-assisted breast biopsies are percutaneous procedures that rely on stereotactic mammography or ultrasound imaging. Stereotactic mammography involves using computers to pinpoint the exact location of a breast mass based on mammograms taken from two different angles. The computer coordinates will help the physician guide the needle to the correct area in the breast

Mammography

Needle biopsy

Needle biopsy

In this technique, a large bore needle is inserted into a tissue mass to extract one or many cores of tissue. If a suspected tumour is inaccessible or located deep within the body, it may be necessary to use ultrasound imaging or a CT (computerised tomography) scanner in order to precisely position a needle through which a biopsy sample can be removed

Positron emission tomography with fluorodeoxy- glucose (PET with FDG)

The PET technique involves the use of radioactive material in the diagnosis of cancer. In this method, the patient is injected with the radioactive substance fluorodeoxyglucose (FDG), a compound taken up by metabolically active tissues. As cancer cells are more metabolically active than normal tissues, the tumour tissue will take up relatively more radiolabelled substance. The patient is placed in a scanner to detect the radiation. This test may be particularly useful to determine the spread of cancer to other sites in the body. The main advantage of PET is that it can diagnose diseases even before the structural changes are visible. Since, it utilizes isotopes of basic biological elements like carbon, oxygen, and nitrogen, it reveals the disease status at a more cellular level than other types of imaging techniques

Positron emission tomography

Punch biopsy

Punch biopsy

The instrument used is a hollow tube that is rotated into the skin until a core of tissue from the proper depth is obtained. This technique is used to obtain a deep core of skin and underlying tissue but is also used to examine the cervix following an abnormal cervical smear

Sentinel node biopsy

This is used to check if an existing breast cancer has spread to lymph nodes. In the procedure, dye or radioactive material is injected into the region of a tumour which is then followed as it moves toward the lymph nodes. The first one it reaches is the sentinel which is then removed for histology

Sentinel node biopsy

Shave and scoop biopsy

Shave and scoop biopsy

This is a method of obtaining a biopsy sample from a skin lesion. A scalpel is used to literally shave off the surface of a lesion and is commonly used to evaluate pigmented moles (suspected melanomas) or other tumours involving the skin (A). If the lesion is malignant then the scoop procedure will be necessary to remove the remaining portion (B)

Smears

In a smear, individual cells are removed using either a very thin needle or by scraping a surface with an instrument. The cells obtained are carefully smeared onto a glass slide, stained and examined microscopically. Cervical (Papanicolaou or Pap) smears are routinely used to examine cells from the surface of the cervix. In this procedure, the surface of the cervix is scraped with a spatula-shaped instrument to obtain a sample of cells

Smears

Stereotactic biopsy

Stereotactic biopsy

This is a specialized radiology technique used to evaluate masses that are either too small to be felt directly through the skin or located in an inaccessible part of the body. It is most frequently used to evaluate breast masses where X-rays from two angles and a computer are used to locate the lump, and then a core needle is inserted into the breast for a tissue sample. With sophisticated radiological equipment, the suspicious mass is localized and a small incision made directly above. The radiologist or surgeon then uses a needle to extract several cores of tissue

Tomosynthesis

X-ray technology that offers high precision, multi-slice imaging at low exposure to visualize areas that are invisible by conventional radiography

Tomosynthesis

Transurethral resection of bladder

Transurethral resection

This involves surgical removal of the prostate or bladder lesions by means of an cystoscope inserted through the urethra, usually for the relief of prostatic obstruction or for treatment of bladder malignancies

Trephine biopsy

Bone marrow is located in the centre of many bones and is responsible for producing blood cells. The needle trephine removes a sample of the marrow which is used for the diagnosis and staging of cancers involving the blood cells which include lymphoma, leukaemia and metastatic disease

Trephine biopsy

Ultrasound

Ultrasound

Ultrasound is used to help evaluate suspicious lesions in pre-menopausal women or evaluate breast abnormalities found on a mammogram. The ultrasound method comprises a small transducer which is able to slide along the skin, sending short bursts of high-frequency sound waves into the tissue. The sound waves will either bounce off the tissue or pass through it. The patterns of the sound waves that bounce off the tissue produce a picture of the mass from which it is possible to ascertain whether the mass is solid, semi-solid or a fluid-filled cyst

Vacuum-assisted biopsies

These are usually used for sampling breast tissue and are referred to by their brand names of Mammotome or MIBB (Minimally Invasive Breast Biopsy). The Mammotome procedure uses a tiny hollow needle probe, which is guided to the abnormal area by computer images projected on two screens (a stereotactic view) or by ultrasound. The needle is inserted into the breast tissue and uses a vacuum to withdraw the tissue, which is removed by a high-speed rotating cutter. The probe can obtain more than one sample, if necessary, without being withdrawn and reinserted. The physician simply repositions it and activates another rotation. A physician gets about 10 times as much breast tissue from the Mammotome procedure as from a core needle biopsy. The MIBB instrument resembles a radiolucent needle, making it easier to see on an X-ray. A specimen collection chamber is located below the tip with a vacuum unit that pulls the tissue into the chamber

Vacuum-assisted biopsy

Wire localization biopsy

Wire localization biopsy

This is a specialized procedure used for small or non-palpable breast masses. Using X-ray or ultrasound guidance, the mass is located under anaesthetic and a thin wire is carefully inserted into the suspicious area. The surgeon uses the tip of the wire as a guide to locate and remove a sample for histology

Adverse effects of tissue sampling

Irrespective of how careful biopsies are carried out, they are invasive techniques and as such carry elements of risk. Consequently, in order for patients to benefit from these procedures, there must be a real clinical indication for carrying them out. Risks with certain types of biopsy such as those from the skin are far less hazardous than with those of the liver for example. The risks of some of the more common biopsy sites are outlined below:

Specific risks of biopsy procedures include infection from a contaminated biopsy instrument or site, perforation of a tissue or organ, vascular problems such as bleeding from the biopsy site, dissemination of the tumour and induction of reactive changes which on subsequent biopsy may be misinterpreted. However, depending on the localization, other potential complications such as local paralysis, pneumothorax and sepsis may occur. With the stereotactic brain biopsy for example, the risks include stroke, seizure and even death.

 Vascular damage Perforation of tissue or organ

Bleeding from biopsy site or internal bleeding into body cavity or duct

Leakage of contents or incident such as pneumothorax following lung biopsy

 Induction of reactive change Infection by contamination

Formation of granulomas at previous biopsy site

Biopsy site is a means of bacterial entry. Infection of site may also arise from contaminated biopsy instruments

Dissemination of tumour

Seeding of biopsy tract and contamination from blood and surgical instruments

Sampling of tissue inside the laboratory

The ability to accurately examine, describe and process gross specimens is one of the most important skills of the pathologist. Although this is rather obvious for the processing of entire biopsy specimens, the description of large surgical specimens provides a permanent record of all relevant information. This should include all the demographic and clinical information provided by the submitting physician, the observations made at the time of dissection and a description of samples taken. At the time of gross examination, resection margins of small biopsies are not generally marked with ink since delineation of surgical margins is not necessary. Simple specimens such as polyps with clear anatomic landmarks can be marked with ink at their surgical margins if required. With few exceptions, tissue samples arrive in the laboratory immersed in the fixative formalin (see the chapter on 'Formalin and tissue fixation').

All specimens obtained from surgery with intent to cure should be inked at their surgical margins. In the laboratory, methods for assessing the specimen margins may either be parallel to the plane of resection (en face) or perpendicular to the plane of resection. The advantage of sampling a margin en face is that a large surface area can be examined as seen with the entire circumference of bowel resection margins. Although the margin can be called completely negative if no tumour is seen, the disadvantage is that the exact distance of the tumour to the margin cannot be determined.

A - Tumour, B - Normal tissue, C - Margin

Importantly, if any tumour is identified in an en face margin, the margin must be considered positive. The advantage of sampling a margin perpendicularly is the ability to determine precisely the distance of tumour from the margin. Thus, perpendicular margins are recommended when the tumour approaches closely (within 2.0 mm) to what otherwise would be considered a negative margin. The disadvantage is that very little of the margin is actually sampled. Margins are optimally inked and allowed to dry while the specimen is fresh, prior to preliminary dissection. Generally, rules for surgical resection margins are that all tissue samples with intent to cure should be inked. Both proximal and distal margins should be sampled wherever possible to include perpendicular to plane of resection or parallel to plane of resection.

Sampling of margins

If the tissue is received unfixed, frozen sections, imprint smears or samples for microbiological investigations may also be taken before the tissue is fixed in 10% formalin or other preferred fixative. At cut up, the pathologist can integrate the gross and microscopic appearances to arrive at a diagnosis. Surgical resections for tumour must be accurately described and measured with photographs and diagrams showing the sites of the selected tissue blocks. From these samples, the histopathologist will not only be able to diagnose the tumour type but will also be able to report on the extent of spread, the adequacy of resection and the presence of local precancerous lesions. Samples that include the edge of a tumour are usually more informative and although a single block is invariably sufficient, several blocks are usually taken. Sampling of blood vessels should also be performed to show the presence of vascular permeation. This should be performed in conjunction with the thorough sampling of nodes to show the extent of lymph node involvement and it is important that a standard sampling method is followed. Palpation of nodes is best avoided since it biases the sampling in favour of involved nodes. An alternative and better method is to slice the fat at regular intervals and process all nodes presenting at the cut surfaces.

Because antibiotic therapy is generally the first treatment of choice for specific infective processes, surgical resections are rarely performed unless they are found unexpectedly during surgery. Fresh samples of these tissues must be taken for microbiological studies before tissues are fixed. Culture is essential since some infections may only show sparse organisms that may not be detected by Gram stain or Ziehl Neelsen in paraffin sections. Resections and resection margins for chronic inflammatory bowel disease need to be sampled carefully because the lesions and granulomas may be sparse and patchy and precise location will therefore be required.

The difference between the amount of tissue sample taken and the object as a whole is known as sampling error and it may or may not be representative. The fact that changes in some diseases are localised rather than diffuse can cause diagnostic problems if sufficient slicing of the tissue is not performed (see figures below). By maintaining consistency, this can be overcome by taking what is regarded as an adequate number of blocks of larger pieces of tissue or resections. However, in small samples where only a single block is available, then it is equally important to examine deeper sections throughout the block to ensure that sampling errors are minimised.

Some diseases give rise to diffuse changes; many diseases give rise to focal changes

Sampling of tissue

Key: A. Tumour edge B. Background C. Resection margin D. Representative nodes Dh. Highest node E. Vascular pedicle

For most diagnostic purposes, paraffin sections are cut at about 5 μm, although there are some uses for sections to be cut thicker or thinner. Thick sections will reduce sampling error but are virtually useless for diagnosis of most lesions because of superimposition. However, a 20 μm section can be a useful way to find pathogens such as bacteria or asbestos fibres provided the microscope is focused through all planes of the section during the examination. Frozen sections too, can be cut at 10 μm or greater and still provide a diagnosis particularly with staining methods associated with the nervous system. Although paraffin wax sections can be cut thinner than 5 μm, it is easier to use tissues that have been embedded in acrylic or epoxy resins since it provides greater support. Current applications include renal biopsies, lymph node biopsies and bone marrow trephines. The clarity provided by 1 μm plastic sections is due to the virtual elimination of superimposition of cells and to the considerable reduction in tissue shrinkage when compared with paraffin wax sections.

Diagnostic histopathology is an important requirement for both clinical practice and the management of patient care. The evidence provided of the many processes involved has shown that the interaction between the clinician and the laboratory is as vital as the ability of the pathologist to correctly interpret different abnormal states. Although microscopic examination of tissues is the main histological method of diagnosis, the technology of the modern era has changed all that. Storage of photographs as whole slide images has transformed the way that the processes of interpretation and diagnosis are now managed. The viewing experience of digital images to that of conventional microscopy is described at the end of the 'Staining' section.

Whole mount, large format histology

In cancer pathology, the application of whole mount, large format histology (WMLFH) processing is an established method for assessing characteristics such as intra-tumour heterogeneity, distribution and surgical margin involvement of large tumour samples. This method has proven to be cost effective and is able to meet the needs of the laboratory in the multidisciplinary approach to cancer diagnosis. This processing system represents a transformative advancement in biomedical imaging, moving beyond the inherent limitations of conventional two-dimensional (2D) histological analysis. By enabling the visualization of entire organs or large tissue sections in their original three-dimensional (3D) context, WMLFH provides unprecedented spatial information crucial for understanding complex biological systems and disease progression. This report defines WMLFH, elucidates its core scientific principles, details key methodologies, and explores its diverse applications across neuroscience, oncology, and regenerative medicine. While technical hurdles, significant data management challenges, and high costs currently limit widespread adoption, ongoing innovations in tissue clearing, advanced labeling, novel imaging modalities, and the synergistic integration with artificial intelligence (AI) are rapidly propelling WMLFH towards broader clinical translation. The ability of WMLFH to offer a comprehensive, contiguous view of tissue, revealing clinically significant findings often missed by traditional methods, positions it as a foundational technology for enhancing diagnostic accuracy, improving patient care, and serving as a critical "ground truth" for multimodal biomedical integration.

1. Introduction

1.1 Defining whole mount and 3D histology

Whole mount large format histology (WMLFH) is a specialized histopathological technique that involves preparing an entire tissue slice, often a full cross-section of an organ or a substantial specimen, on a single, oversized microscope slide without further fragmentation. This approach stands in stark contrast to conventional histological methods, which typically involve sectioning tissue into numerous smaller fragments for individual slide mounting. The primary objective of WMLFH is to preserve the macroscopic and microscopic continuity of the tissue, allowing for a comprehensive, uninterrupted view of its architecture. The broader concept of 3D histology encompasses WMLFH and refers to any process that facilitates the visualization of tissues in their original, volumetric structure, rather than as discrete 2D sections. This is achieved primarily through advanced tissue clearing techniques that render intact biological tissues transparent, enabling rapid and detailed interrogation of their internal architecture in three dimensions. While "whole-mounts" can also refer to very small organisms or thin membranes placed directly on a slide , the focus within this report is on the application of these advanced techniques to larger, opaque biological specimens, such as organs or significant portions thereof, to reveal their intricate internal organization.

1.2 Comparisons with conventional 2D histology

Traditional histopathology relies on the preparation of micrometer-thick tissue sections, typically stained with hematoxylin and eosin (H&E), for observation under an optical microscope. While this conventional 2D approach offers detailed structural examination within a single plane, it possesses an inherent limitation: it reduces the body's intrinsically 3D structures to individual 2D planes. This fundamental act of sectioning, while enabling microscopic detail, inherently sacrifices continuous spatial context. A critical diagnostic vulnerability arises from this dimensionality reduction. The ability of a histopathologist to mentally reconstruct the full 3D pathology from a series of sequential 2D slices is highly subjective and can lead to missing crucial information, especially in cases of diffuse or multifocal disease processes. The perception of structures outside the immediate 2D section becomes dependent on the pathologist's individual experience and interpretive skill. Visualizing and accurately understanding the complex 3D spatial relationships of cells and molecules is profoundly difficult using conventional methods.

In contrast, 3D and large format histology offer several compelling advantages:

Comprehensive view: WMLFH provides a complete and comprehensible view of large tumor lesions or entire organ cross-sections. This is invaluable for accurately identifying deviations from normal features and understanding complex pathologies, as it maintains the integrity of the tissue section throughout the embedding and sectioning process.
Enhanced diagnostic accuracy: Large format histology has demonstrated unique advantages in detecting unsuspected pathologic findings of significant clinical relevance that might be overlooked in standard 2D slides. A multiyear study revealed that 25% of cases exhibited unexpected findings (e.g., closer surgical margins, changes in disease size or extent, or previously undocumented invasive and/or in situ carcinoma) that were only identifiable through large format sections. This enhanced legibility significantly improves the efficiency of histopathologic examination and has been associated with a higher detection rate of adverse pathological events, such as positive surgical margins. This represents a direct, quantifiable improvement in diagnostic accuracy that can directly influence patient management, surgical planning, and prognosis. The implication is that conventional 2D histology, despite its long-standing role, routinely misses clinically relevant information due to its inherent limitations.
Spatial context preservation: Unlike 2D sections where structural relationships are fragmented, WMLFH preserves the native structural relationships between individual cells and extracellular components. This is particularly critical for unraveling the organization of complex structures, such as the human amygdala.
Improved pathologic-imaging correlation: WMLFH facilitates superior correlation with pre-operative imaging data and enhances the overall pathologic-imaging correlation. This is paramount for multimodal research and clinical applications, where integrating macroscopic imaging with microscopic pathology is essential.
Reduced variability: The whole-mount sampling approach inherently reduces variability between different operators, thereby improving the consistency and reliability of pathologic examination results.
Educational benefits: The enhanced legibility and direct anatomical correspondence offered by WMLFH sections significantly reduce the challenges associated with identifying pathologic features for inexperienced pathologists. This directly facilitates the understanding and learning process, providing invaluable educational benefits for personnel training.

The shift from 2D to 3D histology represents a fundamental paradigm change, transforming pathology from a subjective mental reconstruction of 3D reality based on 2D data to an objective, direct 3D visualization.

2. Core scientific principles

2.1 Tissue clearing

Biological specimens are inherently three-dimensional, yet imaging deep into their volumetric structure has historically been problematic due to the obscuring effects of light scatter. Tissue opacity primarily arises from the heterogeneous distribution of components within cells and extracellular spaces, which results in varying refractive indices (RI). When light passes through these different RIs, it is scattered, leading to image distortion and a loss of clarity. The core principle of tissue clearing is to homogenize these differences in refractive indices across the entire tissue sample. By immersing the tissue in an appropriate chemical agent, the goal is to create an optically uniform environment that allows light to pass through the sample with minimal scattering. This intricate interplay between the physical phenomenon of light scatter and the chemical manipulation of tissue properties forms the bedrock of 3D histology. The transparency achieved is not merely a "cleaning" of the tissue but a carefully engineered optical property. This process typically involves several key steps: fixation to preserve tissue integrity, permeabilization to allow chemical penetration, decolorizing to remove light-absorbing pigments, and finally, refractive index matching to render the tissue transparent.

2.2 Hydrogel embedding and removal of fats

Many advanced tissue clearing methods, particularly those based on the CLARITY technique, employ a sophisticated strategy involving hydrogel embedding followed by lipid removal to achieve optical transparency. The process begins with hydrogel embedding. A fixed tissue sample is introduced into a solution containing hydrogel monomers and cross-linkers. These small molecules are designed to diffuse uniformly throughout the tissue and bind specifically to biomolecules such as proteins and nucleic acids. Crucially, they do not bind to the light-scattering lipids. Following diffusion, the hydrogel-infused tissue undergoes thermal treatment, which triggers the polymerization of the monomers. This polymerization forms a stable, porous mesh that effectively locks the biomolecules in their original spatial positions, thereby preserving the tissue's structural integrity and spatial orientation. After the tissue is structurally stabilized within the hydrogel, the next critical step is lipid removal. Lipids are a primary contributor to light scattering and tissue opacity. Detergent solutions are then used to extract these lipids and other unbound molecules from the hydrogel-tissue hybrid. The removal of these light-scattering components renders the tissue optically clear. Lipid extraction can be achieved through two mechanisms:

Passive thermal diffusion: In this method, tissues are incubated in detergent solutions, such as sodium dodecyl sulfate (SDS), at controlled temperatures with gentle shaking. This allows lipids to passively diffuse out of the tissue. While generally less prone to tissue deformation, this method can be slower, often requiring days to weeks for complete clearing.
Electrophoresis: This more rapid method involves applying an electric field across the tissue while circulating a clearing solution. The electric field actively drives the removal of solvated lipids, significantly accelerating the clearing process. Examples include Electrophoretic Tissue Clearing (ETC) and Stochastic Electrotransport. More advanced active methods, such as CRYSTAL, direct detergent streams at specific areas of the tissue, acting like a "pressure washer" to further speed up the clearing process compared to passive diffusion.

The intricate design of these clearing methods, where the "transparency" is a carefully engineered optical property, underscores the sophisticated chemical manipulation of tissue properties to achieve high-resolution 3D visualization.

3. Key Methodologies and Techniques

3.1 Tissue preparation and fixation

The foundation of successful whole mount large format histology lies in meticulous tissue preparation and fixation. The process typically begins with the resection of a specimen of appropriate size, followed by fixation in formalin, a common practice in conventional 2D histology. Fixed tissue samples, whether human, mouse, or rat, are the starting material for these advanced techniques. It is important to note that some methods are also compatible with previously frozen, fresh, or formalin-fixed paraffin-embedded (FFPE) tissue. Proper fixation is paramount as it preserves cells and other tissue elements in a "life-like" state, preventing degradation and maintaining structural integrity for subsequent hydrogel embedding and clearing steps. Furthermore, precise adjustment of the mixture ratios of fixatives, such as paraformaldehyde (PFA), and hydrogel components, like acrylamide, is essential. This careful balancing act ensures optimal hydrogel rigidity and porosity, minimizing protein loss while maximizing the efficiency and speed of tissue clearing.

3.2 Tissue clearing methods

Numerous tissue clearing methods have been developed, each with distinct physicochemical principles of operation, allowing researchers to select the most appropriate technique for their specific research questions and tissue types.

CLARITY (Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging / Immunostaining/in situ-hybridization-compatible Tissue hYdrogel): This pioneering technique transforms intact biological tissues into a nanoporous hydrogel-tissue hybrid. It is renowned for preserving anatomical structures, proteins, and nucleic acids, enabling multiple rounds of immunostaining and imaging. Initially developed for brain tissue, CLARITY methods are now applied to a wide array of intact biological samples, including tumors, various organs (e.g., kidney, spleen, lung, tonsil, pancreas, liver, mammary), bone, and organoids. The core process involves hydrogel embedding, followed by lipid removal (either passively or actively), and finally, refractive index matching. Several variants have emerged to optimize the original protocol, including PACT (Passive CLARITY Technique), PARS (Perfusion-assisted Agent Release in situ), ACT-PRESTO, psPACT, and mPACT.
X-CLARITY: This system builds upon the CLARITY method, offering a standardized, simplified, and accelerated approach to tissue clearing. It employs an X-CLARITY™ Hydrogel Solution Kit for uniform monomer diffusion, an X-CLARITY™ Polymerization System for hydrogel formation, and an Electrophoretic Tissue Clearing System II for efficient lipid extraction.
ScaleS/H: The ScaleS method has consistently demonstrated superior performance for whole-mount retinas, significantly improving tissue transparency and immunohistochemical clarity compared to other tested methods. ScaleH is a refined version of ScaleS, incorporating polyvinyl alcohol to reduce fluorescence decay and enhance sample stability. This modification makes ScaleH highly compatible with both immunolabeling and endogenous fluorescent reporters, facilitating improved visualization of transplanted human stem cell-derived retinal neurons in mouse retinas and showing potential for broader neurobiological applications.
Solvent-based clearing: These methods involve dehydrating the tissue, solvating lipids using organic solvents such as Dibenzyl ether (DBE) or Dichloromethane (DCM) and then performing refractive index matching. They are generally inexpensive and can clear samples relatively quickly (within days). However, significant drawbacks include considerable tissue shrinkage (up to 50%), quenching of most fluorescent proteins, and the use of toxic compounds.
Simple immersion techniques (e.g., FocusClear, FRUIT, SeeDB): These methods utilize aqueous solvents like sucrose, fructose, or formamide for tissue immersion, followed by refractive index matching in the mounting medium. They are advantageous for preserving fluorescent proteins and maintaining tissue morphology. Nevertheless, their effectiveness can be limited for dense tissues, they tend to be more expensive, and their clearing times can be highly variable.
Hyperhydration methods (e.g., Scale, CUBIC): These techniques achieve refractive index homogenization by hydrating protein aggregates using urea or similar molecules, which causes them to expand. They are useful for clearing tissues without the complete removal of lipid components. A notable disadvantage is their susceptibility to non-uniform tissue overexpansion, which can alter the structure and morphology of the region of interest, along with inconsistent clearing times.
Hydrogel embedding methods (e.g., X-CLARITY): As detailed, these methods actively clear lipids via electrophoresis after binding subcellular components to a hydrogel polymer. They offer rapid clearing (days), excellent fluorescence preservation, and minimal tissue expansion, leading to highly replicable results. The primary limitations include a higher initial startup cost compared to other methods and the necessity for constant monitoring to prevent tissue damage from high voltages and temperatures during electrophoresis.

The selection of a tissue clearing method involves a careful consideration of various trade-offs. For instance, electrophoretic methods like X-CLARITY offer speed and superior fluorescence preservation but come with a higher initial investment and require meticulous oversight to prevent tissue damage. Conversely, solvent-based methods are cost-effective and fast but induce significant shrinkage and quench fluorescence. Simple immersion methods preserve fluorescence but are slow and less effective for dense tissues, while hyperhydration methods can lead to non-uniform tissue expansion. This inherent complexity means there is no universal "best" method; the optimal choice is dictated by the specific research question, the type of tissue being studied, the desired outcome (e.g., preservation of specific proteins or RNA, morphological accuracy versus fluorescence signal), and the available resources. This necessitates expert consultation and careful experimental design in WMLFH workflows. To provide a concise overview, the following table summarizes the comparative aspects of major tissue clearing methods:

Table 1: Comparative analysis of major tissue clearing methods

Category - Principle - Advantages - Disadvantages - Applications - Tissue types

CLARITY/X-CLARITY - Hydrogel embedding and lipid removal; Preserves structure, proteins, nucleic acids; Multiple immunostaining rounds; Rapid (active); Fluorescence preservation, minimal expansion and replicable results; High initial cost (active); Requires monitoring for over-clearing; Potential tissue deformation (active); Brain, spinal cord, tumors, various organs (kidney, spleen, lung, tonsil, pancreas, liver, mammary), bone, organoids, dense tissues

ScaleS/H - Hyperhydration (urea/polyvinyl alcohol); Increased transparency & immunohistochemical clarity; Reduced fluorescence decay; Enhanced sample stability; Compatible with immunolabeling & endogenous reporters; Prone to non-uniform tissue overexpansion; variable clearing times; Whole-mount retinas, optic nerve, neurobiological applications

Solvent-based (e.g., BABB, DISCO) - Dehydration and lipid solvation with organic solvents; Relatively inexpensive; fast (days); Significant tissue shrinkage (up to 50%); fluorescence quenching; toxicity; artifacts at high magnification; Mouse heart, mouse brain, mouse colon (less effective for colon)

Simple immersion (e.g., FocusClear, SeeDB) -
Aqueous immersion + RI matching; Preserves fluorescent proteins; maintains tissue morphology; Limited effectiveness for dense tissues; high cost; variable clearing times; pigmented patches; Tissues with fragile fluorescent proteins, compromised structural integrity

Hyperhydration (e.g., CUBIC) - Hydrating protein aggregates (urea) causing expansion;
Useful for clearing tissues without lipid removal; Prone to non-uniform tissue overexpansion; variable clearing times; Various tissues (general)

3.3 Staining and labeling techniques for 3D visualization

Once tissues are cleared, specific staining and labeling techniques are employed to visualize target structures in 3D. These methods are crucial for extracting meaningful biological information from the transparent samples. Visualization can be achieved via:

Genetically encoded fluorescent reporters: These involve the genetic introduction of fluorescent markers into cells or organisms, allowing for intrinsic fluorescence of specific proteins or cell types.
In vivo labeling: This approach utilizes viruses or chemicals delivered in vivo to label specific cells or structures prior to tissue extraction and clearing.
Chemical / antibody staining: This is a widely preferred method for cleared tissues, as it allows for multiple rounds of staining without damaging preserved tissue structures.
- Immunohistochemistry (IHC) and Immunofluorescence (IF): These techniques involve incubating tissue sections or cells with specific antibodies that bind to target antigens. Detection is commonly achieved using colorimetric reactions or fluorescent signals. Importantly, these methods can be adapted for thick cross-sections or entire tissue whole mounts , including specialized techniques like Opal multiplex immunohistochemistry.
- DeepLabel™ Antibody Staining Kit: This specialized kit is designed to enhance the penetration of antibodies into clarified tissues, ensuring uniform and efficient labeling throughout the sample.
- CuRVE/eFLASH: A novel method developed at MIT for ultrafast protein labeling in organ-scale tissues. This innovative approach overcomes the traditional speed mismatch between antibody permeation (slow) and binding (fast), which often leads to uneven labeling in thick tissues. CuRVE/eFLASH achieves this by using deoxycholic acid to continuously modulate the pace of antibody binding while simultaneously accelerating antibody movement through stochastic electrotransport. This method has demonstrated the capability to uniformly label whole organs (e.g., brains, embryos, lung, heart) with >60 different antibodies within a single day, offering unprecedented uniformity and versatility.
Nucleic acid probes: These probes are used to detect specific RNA or DNA molecules within the cleared tissue. Examples include single-molecule fluorescence in situ hybridization (sm-FISH) and single-molecule hybridization chain reaction (smHCR) for high-resolution RNA detection.

3.4 Advanced imaging modalities

Once the tissue is transparent and labeled, advanced optical sectioning microscopy techniques are employed to acquire 3D data.

Light Sheet Microscopy (LSM): This is a primary and highly effective modality for 3D histology. LSM offers significantly higher imaging speeds (two to three orders of magnitude faster than conventional confocal microscopes), a superior signal-to-noise ratio, and reduced photobleaching. It achieves this by illuminating only a thin focal plane within the sample and detecting the emitted fluorescence perpendicularly to the illumination plane. This orthogonal setup improves image quality and imaging depth. LSM is particularly well-suited for imaging whole cleared organs or large embryos.
Confocal Microscopy: While capable of optical sectioning, standard confocal microscopes can be slow for large samples and are more prone to photobleaching.
Two-photon Microscopy: This technique offers lower photobleaching and greater imaging depth than confocal microscopy. However, it still relies on point-by-point scanning, making it relatively slow for large-volume imaging.
SPED (SPherical-aberration-assisted Extended Depth-of-field) Light Sheet Microscopy: This advanced variant of LSM combines an extended depth-of-field with optical sectioning. It eliminates the need for physical scanning of detection objectives for volumetric imaging, allowing for the acquisition of thousands of volumes per second.

The choice of microscope objective parameters is also critical for optimal imaging of cleared tissues. A long working distance (WD) is essential for imaging large samples without physical contact with the lens, while a high numerical aperture (NA) provides higher resolution. For cleared tissues, which typically have an average refractive index of approximately 1.46, objectives designed with an RI close to this value are preferable.

3.5 Reconstruction in 3D and image analysis

Following the acquisition of sequential 2D images from the cleared and labeled tissue, specialized software is used to reconstruct these images into a cohesive 3D model. This 3D model then undergoes rigorous analysis to extract relevant information, including quantitative structural data and spatial relationships between various cellular and tissue components. However, this stage presents significant challenges. Scaling digital image analyses to the vast multi-terabyte (multi-TB) datasets generated by WMLFH requires substantial computational resources and expertise. Additional complexities arise from challenges in cell type classification, the translation and visual representation of spatial aspects from high-dimensional data, and the need to mitigate various tissue handling and technical artifacts that can compromise image quality. These artifacts include bubbles, dust, debris, crush injuries, inaccurate image stitching, uneven illumination, and antibody aggregates.

To address some of these limitations, computational tools like PythoStitcher have emerged. This software can reconstruct "artificial whole-mount sections" from digitized tissue fragments. This innovation directly addresses the practical difficulties and costs associated with physically preparing whole-mount sections, particularly the limitations of most whole-slide scanners that cannot accommodate the larger slides required for WMLFH. PythoStitcher automates the determination of how fragments need to be reassembled, iteratively optimizes the stitch using a genetic algorithm, and efficiently reconstructs the final artificial whole-mount section at full resolution. This computational approach provides a crucial "digital bridge," democratizing access to the benefits of whole-mount histology, such as improved correlation and a comprehensive view, even for institutions lacking the specialized hardware or expertise for physical WMLFH. It expands the reach and utility of the concept without requiring a complete overhaul of existing infrastructure.

4. Diverse applications

Whole mount large format histology has emerged as a powerful tool with diverse applications across various biomedical research and clinical fields, offering unique insights into complex processes.

4.1 Neuroscience: Brain organization and neural circuitry

WMLFH, particularly when integrated with CLARITY-based techniques, is exceptionally well-suited for examining the central nervous system, including the mouse brain and spinal cord, in their intact state. This capability allows for the visualization of cellular structures within their native physiological context, which is fundamental for understanding the intricate function of mammalian brains. Key applications in neuroscience include:

Elucidating structure-function relationships: WMLFH enables the study of complex structure-function relationships within specific brain regions, such as the human amygdala. By combining high-resolution histology with magnetic resonance imaging (MRI), researchers can elucidate microstructural organization and its precise mapping onto functional organization.
3D histological valuation: The technique facilitates rigorous 3D histological evaluation of intact, transparent tissues, leading to improved visualization of neuronal tracts and fibers. This provides profound insights into processes of neurodegeneration and neuroregeneration. Specific examples include the delineation of corticospinal projection pathways and the visualization of axonal branching patterns following nerve injuries.
Extracting structural information: The ability to image deep into brain tissues is critical for extracting comprehensive structural information, which is essential for a complete understanding of brain function.

4.2 Oncology: Tumor microenvironment and cancer progression

In oncology, WMLFH offers significant potential for enhancing diagnostics and understanding the complex tumor microenvironment (TME).

Comprehensive Pathology Detection: WMLFH has the potential to detect the full pathology in whole FFPE tissue blocks, serving as a valuable complementary method to rapid conventional 2D histology.
Global Perspective on Disease: It allows scientists to focus on diseased or damaged structures within tissues without losing a global perspective, which is crucial for comprehensive cancer studies.
Prostate Cancer Diagnosis and Prognosis: For prostate cancer (PCa), WMLFH provides precise information vital for diagnosis and prognosis, offering a complete and comprehensible view of large tumor lesions. It has been shown to improve the detection rate of adverse pathological events, such as positive surgical margins.
Monitoring Cancer Progression: Emerging technologies, such as nonlinear sound sheet microscopy, can distinguish between healthy and cancerous tissue and visualize the necrotic core of a tumor (where cells die due to lack of oxygen). This capability can assist in monitoring cancer progression and evaluating the effectiveness of treatments.
Assessment of Excision and Residual Disease: WMLFH facilitates the examination of large, diffuse, or multifocal processes, aids in evaluating the adequacy of surgical excisions, and helps quantify residual disease in the neoadjuvant setting.

4.3 Regenerative medicine and developmental biology

WMLFH and its associated tissue clearing methodologies are indispensable for evaluating the efficacy of gene and cell therapies, particularly those aimed at restoring vision in optic neuropathies.

Visualization of Transplanted Cells: Optimized clearing methods like ScaleH enable improved visualization of transplanted human stem cell-derived retinal neurons in mouse retinas. This provides robust, high-resolution imaging essential for evaluating cell integration in regenerative studies.
Broader Neurobiological Applications: The demonstrated improvement in optic nerve imaging with ScaleH suggests its broader potential across various neurobiological applications.
Understanding Developmental Processes: In developmental biology, the ability to image living cells in 3D within whole organs is critical for understanding complex developmental processes over time.

4.4 Other biomedical applications

The versatility of WMLFH extends to a wide array of other intact biological tissues and organs, including the kidney, spleen, lung, tonsil, pancreas, liver, mammary glands, and bone.

3D X-ray Histology (XRH): This modality offers micro-computed tomography (micro-CT) imaging of soft-tissue samples. Its applications include visualizing head and neck tumors, assessing the effectiveness of cancer treatments, and imaging bone vascular networks for osteoporosis studies.
Whole-Body Cell Profiling: Achieving whole-body cell (WBC) profiling of an entire organism is a significant challenge in biology and medicine. However, tissue clearing, combined with advanced optical imaging and image informatics, enables rapid and comprehensive cellular analyses in whole organs and even the entire body. This capability allows researchers to identify cellular circuits across multiple organs and measure their dynamics in stochastic and proliferative cellular processes, such as autoimmune diseases.

The following table provides a structured overview of the diverse utility of WMLFH across different scientific disciplines, highlighting its versatility and the specific problems it addresses.

Table 2: Applications of WMLFH by research area

Research area - Specific applications - Key benefits

Neuroscience: Brain organization, neural circuit tracing, studying amygdala structure-function, neurodegeneration/regeneration, axonal branching patterns; 3D spatial relationships, understanding complex brain function, validation of MRI-based features, insights into disease processes

Oncology: Tumor boundary delineation, metastasis detection, assessment of surgical margins, quantifying residual disease, monitoring cancer progression, visualizing necrotic core; Comprehensive view of tumor lesions, detection of unsuspected findings, improved surgical planning, evaluation of treatment response

Regenerative medicine: Evaluation of gene and cell therapies, visualization of transplanted cell integration, optic nerve imaging; Robust, high-resolution imaging for cell integration assessment, understanding therapeutic efficacy

Developmental biology: Imaging living cells in 3D within whole organs; Understanding complex developmental processes over time

General pathology: Examination of large/diffuse/multifocal processes, whole-body cell profiling, imaging bone vascular networks; Enhanced diagnostic accuracy, improved pathologic-imaging correlation, identification of cellular circuits across organs

5. Advantages and clinical significance

Whole mount large format histology offers profound advantages that extend its utility from fundamental research to direct clinical significance, particularly in enhancing diagnostic capabilities and improving patient care.

5.1 Enhanced diagnostic accuracy and pathological insights

As previously detailed, WMLFH demonstrably improves diagnostic accuracy by providing a complete, contiguous view of large specimens. This comprehensive perspective is critical for revealing clinically significant findings—such as closer surgical margins, the true extent of disease, or previously undocumented invasive and/or in situ carcinoma—that might be missed when relying solely on fragmented 2D sections. The ability to visualize the entire lesion in its anatomical context leads to a higher detection rate of adverse pathological events. This allows for a more comprehensive structural examination of tissue sections in great detail while maintaining the crucial overall 3D context, moving beyond the subjective interpretation of fragmented samples.

5.2 Facilitating pathologic-imaging correlation

WMLFH offers significantly improved correlation with pre-operative imaging and enhances the overall pathologic-imaging correlation. This is particularly valuable in clinical fields such as oncology, where precise anatomical understanding derived from macroscopic imaging modalities (e.g., MRI, CT) needs to be rigorously validated and integrated with microscopic pathological findings. The comprehensive 3D view provided by WMLFH serves as a critical "ground truth" for validating features identified by non-invasive imaging. If MRI-based features, for instance, can be accurately validated against high-resolution 3D histology, it substantially strengthens the diagnostic power and reliability of non-invasive imaging techniques. This means WMLFH is not only a diagnostic tool in itself but also a foundational technology that enables the advancement and validation of other cutting-edge diagnostic approaches.

5.3 Educational benefits

The enhanced legibility and direct anatomical correspondence of WMLFH sections offer irreplaceable educational benefits. Because the appearance of a WMLFH section often mirrors the gross anatomical status of the tissue, it greatly reduces the challenges for inexperienced pathologists in identifying and understanding complex pathologic features. This intuitive visual correlation facilitates the learning process, making it easier for trainees to grasp the spatial relationships of disease processes within the broader tissue architecture.

6. Current limitations and challenges

Despite its transformative potential, the widespread adoption and clinical integration of whole mount large format histology are currently hindered by several significant limitations and challenges.

6.1 Technical hurdles in sample processing and imaging

The technical complexity of WMLFH workflows remains a substantial barrier. Whole-mount sectioning itself is technically difficult and associated with high costs. During processing and imaging, various artifacts can compromise image quality, including tissue handling artifacts (e.g., bubbles, dust, debris, crush, and sectioning artifacts) and technical artifacts (e.g., inaccurate image stitching, uneven illumination, and antibody aggregates).
Specific clearing limitations persist; some tissues, such as the heart, may not clear as effectively or homogeneously as others, retaining internal pigments that can obscure visualization. Furthermore, there is a delicate balance in the clearing process, as over-clearing can lead to irreversible tissue deformation, melting, charring, or disintegration. Certain methanol-based tissue clearing protocols can also restrict the usable antibody portfolio to only those antibodies that are resistant to methanol, limiting the range of molecular targets that can be visualized. While tissue clearing significantly improves imaging depth, achieving high-resolution 3D images of thicker and more complex biological tissue remains challenging, particularly due to persistent light scattering in dense, heterogeneous, and live tissue. Current state-of-the-art optical technologies for deep-tissue imaging typically can only penetrate around 1 millimeter into tissue. Moreover, the imaging process itself can be technically demanding, with manual adjustments of laser power and gain often required as the laser penetrates deeper into the sample. This manual intervention can lead to a lack of homogeneity in the final 3D reconstructions.

6.2 Data management and computational demands

The transition from 2D to 3D histology inherently generates vast amounts of data, often resulting in multi-terabyte (multi-TB) datasets. This presents a significant "big data" problem. The challenge extends beyond mere storage capacity to the substantial computational expertise required for efficient processing, sophisticated analysis, and effective visualization of these enormous datasets. Specific computational challenges include scaling digital image analyses to these large datasets, accurately classifying different cell types within complex 3D environments, and translating and visually representing the spatial aspects of high-dimensional data. The presence of technical artifacts, such as inaccurate image stitching and uneven illumination, further complicates the analytical process, requiring advanced algorithms for correction and compensation. This means that hardware and wet-lab protocols are only part of the solution; advanced bioinformatics and computational infrastructure are equally critical for WMLFH to reach its full potential, as the primary bottleneck has shifted from tissue preparation to data handling and interpretation.

6.3 Cost and accessibility of technology

The specialized equipment required for WMLFH, particularly advanced imaging modalities like light-sheet microscopy, is prohibitively expensive. These setups are currently offered at a very limited number of centers globally, with light-sheet microscopy available at only about 25 centers worldwide. Other advanced microscopy modalities, such as confocal or multiphoton microscopes, are similarly costly. The initial startup cost for hydrogel embedding methods, exemplified by X-CLARITY systems, is also higher than other tissue clearing methods. Furthermore, a practical limitation for broader adoption is that most existing whole-slide scanners are designed for regularly sized microscopy slides and cannot accommodate the larger slides necessary for WMLFH. This incompatibility necessitates either specialized large-format scanners or computational reconstruction from fragmented images, adding to the complexity and cost.

6.4 Regulatory and clinical integration challenges

Integrating WMLFH into existing clinical workflows presents a significant hurdle. For widespread clinical adoption, 3D histology must undergo rigorous comparative studies and clinical validation to conclusively demonstrate that it provides clinically relevant information, improves diagnostic accuracy, and offers tangible value beyond traditional 2D methods. The process of obtaining regulatory approval for these advanced technologies, which are often classified as medical devices, is a complex and time-consuming undertaking.

Finally, there is a considerable learning curve and extensive effort required to train pathologists in the interpretation of complex 3D histology data. This necessitates the development of new educational programs and a shift in diagnostic paradigms, which can be challenging to implement in busy clinical and training environments.

7. Recent advancements and future directions

The field of whole mount large format histology is undergoing rapid evolution, driven by continuous innovation in clearing, labeling, imaging, and computational technologies. These advancements are steadily addressing current limitations and paving the way for broader clinical translation.

7.1 Emerging clearing and labeling technologies

Recent developments are focused on optimizing existing methods and introducing novel approaches:

ScaleH: A modified version of the ScaleS clearing method, specifically optimized for whole-mount retinas, has shown significant improvements. The addition of polyvinyl alcohol to ScaleH reduces fluorescence decay and enhances sample stability. This allows for robust, high-resolution imaging of transplanted human stem cell-derived retinal neurons in regenerative studies and demonstrates potential for broader neurobiological applications.
CuRVE/eFLASH: This ultrafast protein labeling method, developed at MIT, represents a major leap in tissue processing. It effectively resolves the speed mismatch between antibody permeation and binding, allowing for uniform labeling of whole organs (e.g., brains, embryos, lungs, hearts, and human brain tissue blocks) with over 60 different antibodies within a single day. The significance of CuRVE/eFLASH lies in its ability to provide a richer, more complete context for data compared to genetic reporting methods, which can sometimes either underreport or overreport actual protein expression.
Nonlinear sound sheet microscopy: A ground breaking ultrasound-based imaging method has emerged, capable of capturing cells in 3D within whole organs. This technique utilizes sound-reflecting probes (nanoscale gas-filled vesicles) and can image centimeters deep into opaque mammalian tissue, a significant advantage over light-based methods typically limited to approximately 1 millimeter penetration. This technology holds immense potential for brain imaging, enabling the observation of capillaries in living brains, and for cancer research, allowing differentiation between healthy and cancerous tissue and visualization of the necrotic core of tumors. This development is particularly important as it pushes the boundaries beyond traditional light microscopy, addressing the unique demands of in vivo 3D imaging.
Integration of methods: Future advancements will likely involve the synergistic combination of existing clearing methods and learning from other techniques, such as SWITCH (which allows for controlled binding kinetics) and MAP/ExM (which linearly expand tissues to enable subcellular architecture imaging). This suggests a holistic ecosystem of innovation where advancements in one area, like faster labeling, unlock new possibilities in another, such as more comprehensive AI training data, driving a synergistic evolution of the entire WMLFH pipeline.

7.2 Integration with artificial intelligence and machine learning

The conversion of traditional histopathological specimens into high-resolution digital images, a key outcome of WMLFH, fundamentally paves the way for advanced computer-aided analysis and the seamless integration of artificial intelligence (AI) and machine learning (ML). AI and deep learning are recognized as major developments poised to revolutionize pathology. 3D histopathology fosters a strong synergy with AI, as AI algorithms possess the capability to identify subtle or global features within complex datasets that are often difficult for the human eye to perceive. Crucially, WMLFH images can serve as high-fidelity "ground truth" data for training deep learning models designed for AI radiologists, significantly improving diagnostic accuracy and classification performance. Notably, some AI models trained with WMLFH data have demonstrated the ability to detect lesions that were initially overlooked by human radiologists.
Furthermore, 3D histopathology data can offer new, AI-friendly data modalities, such as 3D cell point clouds. These point clouds, extensively used in engineering with machine learning, contain rich spatial context information derived from the complex 3D structures of biological tissues. This modality can also help reduce data size, mitigating some of the computational and storage issues associated with large image datasets. Moreover, the point cloud modality can address the issue of diminished generalizability of AI diagnostic tools, which can arise from variations in H&E-stained slide color and quality between different institutions. The recurring theme of AI/ML integration suggests that AI is not merely an analytical tool for WMLFH data but a critical enabler for its clinical translation, overcoming human limitations and handling the sheer volume of 3D data.

7.3 Automation and workflow optimization

To overcome the technical burden and accelerate the uptake of WMLFH, full automation of the entire workflow, from tissue processing to image acquisition and data processing, is a plausible and actively pursued goal. Companies like ClearLight Biotechnologies are actively working to automate the CLARITY method to make it practical for clinical settings. There is also increasing pressure on laboratories to adopt processors capable of rapid processing to improve workflow efficiency and reduce overall turnaround times.

7.4 Outlook for clinical translation and broader adoption

The future outlook for 3D histopathology is one of significant expansion, poised to deepen our understanding of human pathophysiology and fundamentally improve patient care through cross-disciplinary collaboration and innovation. It is envisioned that WMLFH will be seamlessly integrated into existing pathology workflows, allowing for the reciprocal use of cleared tissues for Light-Sheet Fluorescence Microscopy (LSFM) imaging and formalin-fixed paraffin-embedded (FFPE) tissues for routine pathological examinations and molecular testing. Initial adoption of WMLFH is likely to occur primarily in research settings and large academic institutions. Crucial next steps for broader clinical translation include rigorous comparative studies and comprehensive clinical validation to unequivocally demonstrate its value over traditional 2D methods, as well as the integration of 3D histology interpretation into pathology training programs. Future inventions of devices specifically optimized for clinical use, such as open-top light sheet microscopes and desktop-equipped selective plane illumination microscopy, will further accelerate its adoption.

8. Conclusion

Whole mount large format histology represents a profound paradigm shift in the field of pathology, transcending the inherent limitations of conventional 2D analysis by offering unprecedented spatial context and diagnostic depth. By enabling the direct visualization of entire organs or large tissue sections in their native three-dimensional architecture, WMLFH provides a comprehensive and contiguous view that significantly enhances diagnostic accuracy, revealing clinically significant findings often missed by traditional fragmented methods. This capability also positions WMLFH as a critical "ground truth" for validating and integrating data from other imaging modalities, such as MRI, and for training advanced artificial intelligence algorithms.

Despite its transformative potential, the widespread adoption of WMLFH currently faces formidable challenges, including technical complexities in sample processing and imaging, the immense computational demands of managing multi-terabyte datasets, and the high cost and limited accessibility of specialized equipment. However, the ongoing wave of advancements including novel tissue clearing agents like ScaleH and CuRVE/eFLASH for ultrafast labeling, the emergence of entirely new imaging modalities such as nonlinear sound sheet microscopy for live tissue visualization, and the increasing sophistication of computational tools for 3D reconstruction and analysis are rapidly addressing these limitations.The synergistic integration of WMLFH with artificial intelligence and machine learning is particularly noteworthy. AI is not merely an analytical tool for WMLFH data but a critical enabler for its clinical translation, capable of identifying subtle features beyond human perception and efficiently processing vast data volumes. This creates a positive feedback loop: superior WMLFH data leads to more robust AI, which in turn enhances the clinical viability and interpretability of WMLFH. As automation and workflow optimization continue to mature, the technical burden will decrease, making WMLFH more accessible and practical for routine use. The future of WMLFH promises to fundamentally enhance our understanding of biological systems, revolutionize diagnostic pathology by providing more precise and comprehensive insights, and ultimately contribute to improved patient care through personalized medicine approaches.

Follow the links below for more information on methods of dissecting and processing large format tissue samples.

Website reviewed 4th February 2026